MedTrace Logo

Optimising the Timing of Whooping Cough Immunisation in MUMs

NCT03908164 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 354

Last updated 2021-03-18

No results posted yet for this study

Summary

A multicentre study to evaluate the impact of timing of whooping cough (pertussis) vaccination in pregnancy, with participants randomised to receive whooping cough vaccination at one of three time points in pregnancy.

Conditions

  • Pregnancy Related
  • Immunization; Infection
  • Pertussis

Interventions

BIOLOGICAL

Pertussis containing vaccine

Participants will receive a pertussis containing vaccine licensed for use in pregnancy at one of three time periods.

Sponsors & Collaborators

  • Thrasher Research Fund

    collaborator OTHER

  • Department of Health, United Kingdom

    collaborator OTHER_GOV

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Paul Heath · St George's, University of London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-07
Primary Completion
2020-12-10
Completion
2021-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908164 on ClinicalTrials.gov